{"entity":{"type":"insider","cik":"0001809204","url":"/insider/0001809204","json_url":"/insider/0001809204.json","name":"Cummings Keith Lamont","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":12,"n_filings":9,"first":"2020-12-02","last":"2026-01-22","span_basis":"filed_date"},"name_variants":[{"name":"Cummings Keith Lamont","source":"filing","n_filings":9,"first_seen":"2020-12-02","last_seen":"2026-01-22"}],"transactions":[{"id":5828726,"accession":"0001746473-26-000012","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001746473-26-000012","line_url":"/filing/0001746473-26-000012#line-1","is_derivative":false,"issuer_cik":"0001746473","issuer_name":"PLIANT THERAPEUTICS, INC.","issuer_ticker":"PLRX","issuer_name_source":null,"issuer_url":"/issuer/0001746473","owner_cik":"0001809204","owner_name":"Cummings Keith Lamont","owner_display_name":"Cummings Keith Lamont","owner_url":"/insider/0001809204","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24002.0,"shares_display":"24,002","price_per_share":1.28,"price_display":"1.28","price_state":"stated","total_value":30722.56,"total_display":"30,722.56","total_whole":"30,723","shares_owned_after":297214.0,"shares_owned_after_display":"297,214","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-20","filed_date":"2026-01-22","scope":"insider"},{"id":5219009,"accession":"0001746473-25-000005","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001746473-25-000005","line_url":"/filing/0001746473-25-000005#line-1","is_derivative":false,"issuer_cik":"0001746473","issuer_name":"PLIANT THERAPEUTICS, INC.","issuer_ticker":"PLRX","issuer_name_source":null,"issuer_url":"/issuer/0001746473","owner_cik":"0001809204","owner_name":"Cummings Keith Lamont","owner_display_name":"Cummings Keith Lamont","owner_url":"/insider/0001809204","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20148.0,"shares_display":"20,148","price_per_share":11.2011,"price_display":"11.20","price_state":"stated","total_value":225679.7628,"total_display":"225,679.76","total_whole":"225,680","shares_owned_after":262608.0,"shares_owned_after_display":"262,608","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-17","filed_date":"2025-01-22","scope":"insider"},{"id":2260978,"accession":"0001746473-24-000125","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001746473-24-000125","line_url":"/filing/0001746473-24-000125#line-1","is_derivative":false,"issuer_cik":"0001746473","issuer_name":"PLIANT THERAPEUTICS, INC.","issuer_ticker":"PLRX","issuer_name_source":null,"issuer_url":"/issuer/0001746473","owner_cik":"0001809204","owner_name":"Cummings Keith Lamont","owner_display_name":"Cummings Keith Lamont","owner_url":"/insider/0001809204","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10911.0,"shares_display":"10,911","price_per_share":11.56,"price_display":"11.56","price_state":"stated","total_value":126131.16,"total_display":"126,131.16","total_whole":"126,131","shares_owned_after":282115.0,"shares_owned_after_display":"282,115","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-10","filed_date":"2024-07-12","scope":"insider"},{"id":2328181,"accession":"0001746473-24-000005","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001746473-24-000005","line_url":"/filing/0001746473-24-000005#line-1","is_derivative":false,"issuer_cik":"0001746473","issuer_name":"PLIANT THERAPEUTICS, INC.","issuer_ticker":"PLRX","issuer_name_source":null,"issuer_url":"/issuer/0001746473","owner_cik":"0001809204","owner_name":"Cummings Keith Lamont","owner_display_name":"Cummings Keith Lamont","owner_url":"/insider/0001809204","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9781.0,"shares_display":"9,781","price_per_share":17.23,"price_display":"17.23","price_state":"stated","total_value":168526.63,"total_display":"168,526.63","total_whole":"168,527","shares_owned_after":194605.0,"shares_owned_after_display":"194,605","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-17","filed_date":"2024-01-19","scope":"insider"},{"id":8608347,"accession":"0001209191-23-042825","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-042825","line_url":"/filing/0001209191-23-042825#line-1","is_derivative":false,"issuer_cik":"0001746473","issuer_name":"PLIANT THERAPEUTICS, INC.","issuer_ticker":"PLRX","issuer_name_source":null,"issuer_url":"/issuer/0001746473","owner_cik":"0001809204","owner_name":"Cummings Keith Lamont","owner_display_name":"Cummings Keith Lamont","owner_url":"/insider/0001809204","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19771.0,"shares_display":"19,771","price_per_share":18.0091,"price_display":"18.01","price_state":"stated","total_value":356057.9161,"total_display":"356,057.92","total_whole":"356,058","shares_owned_after":203999.0,"shares_owned_after_display":"203,999","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-17","filed_date":"2023-07-19","scope":"insider"},{"id":7968687,"accession":"0001209191-23-022364","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-022364","line_url":"/filing/0001209191-23-022364#line-1","is_derivative":false,"issuer_cik":"0001746473","issuer_name":"PLIANT THERAPEUTICS, INC.","issuer_ticker":"PLRX","issuer_name_source":null,"issuer_url":"/issuer/0001746473","owner_cik":"0001809204","owner_name":"Cummings Keith Lamont","owner_display_name":"Cummings Keith Lamont","owner_url":"/insider/0001809204","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9960.0,"shares_display":"9,960","price_per_share":26.5209,"price_display":"26.52","price_state":"stated","total_value":264148.164,"total_display":"264,148.16","total_whole":"264,148","shares_owned_after":148470.0,"shares_owned_after_display":"148,470","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-30","filed_date":"2023-04-03","scope":"insider"},{"id":8541192,"accession":"0001140361-23-002783","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-23-002783","line_url":"/filing/0001140361-23-002783#line-3","is_derivative":false,"issuer_cik":"0001746473","issuer_name":"PLIANT THERAPEUTICS, INC.","issuer_ticker":"PLRX","issuer_name_source":null,"issuer_url":"/issuer/0001746473","owner_cik":"0001809204","owner_name":"Cummings Keith Lamont","owner_display_name":"Cummings Keith Lamont","owner_url":"/insider/0001809204","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":35.0,"price_display":"35.00","price_state":"stated","total_value":1050000.0,"total_display":"1,050,000.00","total_whole":"1,050,000","shares_owned_after":84424.0,"shares_owned_after_display":"84,424","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-23","filed_date":"2023-01-25","scope":"insider"},{"id":6859898,"accession":"0001140361-22-046571","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-22-046571","line_url":"/filing/0001140361-22-046571#line-2","is_derivative":false,"issuer_cik":"0001746473","issuer_name":"PLIANT THERAPEUTICS, INC.","issuer_ticker":"PLRX","issuer_name_source":null,"issuer_url":"/issuer/0001746473","owner_cik":"0001809204","owner_name":"Cummings Keith Lamont","owner_display_name":"Cummings Keith Lamont","owner_url":"/insider/0001809204","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9643.0,"shares_display":"9,643","price_per_share":19.1024,"price_display":"19.10","price_state":"stated","total_value":184204.4432,"total_display":"184,204.44","total_whole":"184,204","shares_owned_after":80424.0,"shares_owned_after_display":"80,424","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-20","filed_date":"2022-12-21","scope":"insider"},{"id":2249046,"accession":"0000899243-20-032584","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000899243-20-032584","line_url":"/filing/0000899243-20-032584","is_derivative":false,"issuer_cik":"0001746473","issuer_name":"PLIANT THERAPEUTICS, INC.","issuer_ticker":"PLRX","issuer_name_source":null,"issuer_url":"/issuer/0001746473","owner_cik":"0001809204","owner_name":"Cummings Keith Lamont","owner_display_name":"Cummings Keith Lamont","owner_url":"/insider/0001809204","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18734.0,"shares_display":"18,734","price_per_share":30.000803352193874,"price_display":"30.00","price_state":"stated","total_value":562035.05,"total_display":"562,035.05","total_whole":"562,035","shares_owned_after":23.967,"shares_owned_after_display":"23.97","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-01","filed_date":"2020-12-02","scope":"insider","n_lines":4}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":12,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":12,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":12},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001746473","name":"PLIANT THERAPEUTICS, INC.","url":"/issuer/0001746473","role":"Officer (Chief Financial Officer)","n_filings":9,"first_seen":"2020-12-02","last_seen":"2026-01-22"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001809204","retrieved_at":"2026-08-22T06:31:25+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}